PBLA - What In The World Is Going On With Panbela Therapeutics (PBLA) Stock? | Benzinga
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading higher by 62% to $1.64 during Tuesday's session on upward momentum. The move comes after the company on Monday announced FDA approval of eflornithine, a drug they divested to US WorldMeds, for treating high-risk neuroblastoma ...
PBLA) Stock?>Full story available on Benzinga.com